Literature DB >> 17064752

SIV Vpr evolution is inversely related to disease progression in a morphine-dependent rhesus macaque model of AIDS.

Richard J Noel1, Anil Kumar.   

Abstract

Three of six morphine-dependent monkeys progressed rapidly to AIDS and died by 20 weeks in our SIV/SHIV non-human primate model of drug addiction and AIDS. We studied the evolution of the SIV vpr gene in both cerebrospinal fluid (CSF) and plasma in these rapid progressors, in their normal progressor counterparts and in infected, drug-free controls at 12 and 20 weeks post infection. Viral RNA was amplified, cloned, and sequenced to permit phylogenetic analyses of diversity and divergence of the vpr locus. As we found for SIV tat and env, the vpr gene evolves inversely to the rate of disease progression. Further, we found evidence that compartmentalization of the virus in plasma and CSF is significantly greater in the normal progressors than in the morphine-dependent, rapid progressors. Interestingly, although our previous work with the accessory gene nef indicated no association between disease progression and evolution, the accessory factor, vpr, behaves similarly to the essential lentiviral genes tat and env.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17064752      PMCID: PMC2760771          DOI: 10.1016/j.virol.2006.09.043

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  41 in total

1.  MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment.

Authors:  Sudhir Kumar; Koichiro Tamura; Masatoshi Nei
Journal:  Brief Bioinform       Date:  2004-06       Impact factor: 11.622

2.  The neighbor-joining method: a new method for reconstructing phylogenetic trees.

Authors:  N Saitou; M Nei
Journal:  Mol Biol Evol       Date:  1987-07       Impact factor: 16.240

3.  The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles.

Authors:  E Kondo; F Mammano; E A Cohen; H G Göttlinger
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

4.  Vpr-induced cell cycle arrest is conserved among primate lentiviruses.

Authors:  V Planelles; J B Jowett; Q X Li; Y Xie; B Hahn; I S Chen
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

5.  Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis.

Authors:  W Paxton; R I Connor; N R Landau
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

6.  Modulation by morphine of viral set point in rhesus macaques infected with simian immunodeficiency virus and simian-human immunodeficiency virus.

Authors:  Rakesh Kumar; Cynthia Torres; Yasuhiro Yamamura; Idia Rodriguez; Melween Martinez; Silvija Staprans; Robert M Donahoe; Edmundo Kraiselburd; Edward B Stephens; Anil Kumar
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

7.  Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice.

Authors:  G M Aldrovandi; J A Zack
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

8.  Vpr-mediated incorporation of UNG2 into HIV-1 particles is required to modulate the virus mutation rate and for replication in macrophages.

Authors:  Renxiang Chen; Erwann Le Rouzic; Jessica A Kearney; Louis M Mansky; Serge Benichou
Journal:  J Biol Chem       Date:  2004-04-19       Impact factor: 5.157

9.  A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys.

Authors:  K A Reimann; J T Li; R Veazey; M Halloran; I W Park; G B Karlsson; J Sodroski; N L Letvin
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

10.  Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr.

Authors:  P Di Marzio; S Choe; M Ebright; R Knoblauch; N R Landau
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

View more
  8 in total

1.  Identification and molecular characterization of SIV Vpr R50G mutation associated with long term survival in SIV-infected morphine dependent and control macaques.

Authors:  Ivelisse Rivera; Yashira García; Mohitkumar R Gangwani; Richard J Noel; Lucianette Maldonado; Anil Kumar; Vanessa Rivera-Amill
Journal:  Virology       Date:  2013-08-28       Impact factor: 3.616

Review 2.  Morphine and rapid disease progression in nonhuman primate model of AIDS: inverse correlation between disease progression and virus evolution.

Authors:  Vanessa Rivera-Amill; Peter S Silverstein; Richard J Noel; Santosh Kumar; Anil Kumar
Journal:  J Neuroimmune Pharmacol       Date:  2009-12-16       Impact factor: 4.147

Review 3.  Opiates, immune system, acquired immunodeficiency syndrome, and nonhuman primate model.

Authors:  Richard J Noel; Vanessa Rivera-Amill; Shilpa Buch; Anil Kumar
Journal:  J Neurovirol       Date:  2008-08       Impact factor: 2.643

4.  Analysis of the V1V2 region of the SIV envelope in the brains of morphine-dependent and control SIV/SHIV-infected macaques.

Authors:  Vanessa Rivera-Amill; Richard J Noel; Ivelisse Rivera Román; Yashira García Flores; Shilpa Buch; Anil Kumar
Journal:  AIDS Res Hum Retroviruses       Date:  2009-05       Impact factor: 2.205

5.  Accelerated evolution of SIV env within the cerebral compartment in the setting of morphine-dependent rapid disease progression.

Authors:  Vanessa Rivera-Amill; Richard J Noel; Yashira García; Ivelisse Rivera; Marcus Iszard; Shilpa Buch; Anil Kumar
Journal:  Virology       Date:  2009-12-30       Impact factor: 3.616

6.  Inhibition of Vpx-Mediated SAMHD1 and Vpr-Mediated Host Helicase Transcription Factor Degradation by Selective Disruption of Viral CRL4 (DCAF1) E3 Ubiquitin Ligase Assembly.

Authors:  Hong Wang; Haoran Guo; Jiaming Su; Yajuan Rui; Wenwen Zheng; Wenying Gao; Wenyan Zhang; Zhaolong Li; Guanchen Liu; Richard B Markham; Wei Wei; Xiao-Fang Yu
Journal:  J Virol       Date:  2017-04-13       Impact factor: 5.103

Review 7.  Opiate drug use and the pathophysiology of neuroAIDS.

Authors:  Kurt F Hauser; Sylvia Fitting; Seth M Dever; Elizabeth M Podhaizer; Pamela E Knapp
Journal:  Curr HIV Res       Date:  2012-07       Impact factor: 1.581

Review 8.  Opioid and neuroHIV Comorbidity - Current and Future Perspectives.

Authors:  Sylvia Fitting; MaryPeace McRae; Kurt F Hauser
Journal:  J Neuroimmune Pharmacol       Date:  2020-09-02       Impact factor: 4.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.